| LONZA N | 607.40 / +1.37% |
| Date/Time | 01/25 / 17:30 |
| Chg. / Chg.(%) | 8.20 / +1.37% |
| Bid | - / 40 |
| Ask | - / 304 |
| Open | 601.80 |
| Previous Close | 599.20 |
| High | 610.80 |
| Low | 597.20 |
| Volume [CHF] | 149,396,823.20 |
| Volume [Units] | 246,639 |
| Price fixings | 7450 |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 607.40 |  |
246,639 |
| London Inter.. | 607.40 | |
17,804 |
| Nasdaq Other.. | 681.0000 |  |
124 |
| Lang & Schwa.. | 559.400 | |
|
| Mexico | 13,537.55 | |
210 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
12/16/2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
12/07/2020 / 22:05 - GlobeNewswire
Real-time